Stocklytics Platform
Asset logo for symbol FLGT
Fulgent Genetics
FLGT54
$17.79arrow_drop_down3.36%-$0.62
Asset logo for symbol FLGT
FLGT54

$17.79

arrow_drop_down3.36%

Performance History

Chart placeholder
Key Stats
Open$19.14
Prev. Close$19.16
EPS-5.52
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range18.40
19.49
52 Week Range18.40
30.68
Ratios
EPS-5.52

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Fulgent Genetics (FLGT)

Fulgent Genetics Inc (FLGT) is a leading provider of genetic testing solutions. With a rich history in the field of genetics, Fulgent Genetics has established itself as a trusted partner for healthcare professionals, researchers, and patients alike. The company is dedicated to improving patient care through innovative genetic testing technologies and advanced analytics.
The stock price history of Fulgent Genetics Inc (FLGT) has been impressive, with consistent growth over the years. Investors have benefited from this upward trend, as the stock price has steadily increased. This positive performance can be attributed to the company's strong financials and its ability to adapt to changing market dynamics.
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Ming Hsieh
Headquarters
Temple City
Employees
1012
Exchange
NASDAQ
add Fulgent Genetics  to watchlist

Keep an eye on Fulgent Genetics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Fulgent Genetics 's (FLGT) price per share?

The current price per share for Fulgent Genetics (FLGT) is $17.79. The stock has seen a price change of -$0.62 recently, indicating a -3.37% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Fulgent Genetics (FLGT)?

For Fulgent Genetics (FLGT), the 52-week high is $30.68, which is 72.46% from the current price. The 52-week low is $17.66, the current price is 0.74% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Fulgent Genetics (FLGT) a growth stock?

Fulgent Genetics (FLGT) has shown an average price growth of -3.55% over the past three years. It has received a score of 9 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Fulgent Genetics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Fulgent Genetics (FLGT) stock price performance year to date (YTD)?

As of the latest data, Fulgent Genetics (FLGT) has a year-to-date price change of -39.26%. Over the past month, the stock has experienced a price change of -12.58%. Over the last three months, the change has been -23.19%. Over the past six months, the figure is -20.3%. Looking at a longer horizon, the five-year price change stands at 60.13%.
help

Is Fulgent Genetics (FLGT) a profitable company?

Fulgent Genetics (FLGT) has a net income of -$167.82M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 36.12% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -23.81% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $289.21M, although specific revenue growth data is currently not available. The gross profit is $104.46M. Operating income is noted at -$72.7M. Furthermore, the EBITDA is $71.08M.
help

What is the market capitalization of Fulgent Genetics (FLGT)?

Fulgent Genetics (FLGT) has a market capitalization of $544.14M. The average daily trading volume is 17.95, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level